Management

According to GBI Research, much of the growth is expected due to the approval of many products

A QuintilesIMS report finds that complex generics is a lucrative market for drug manufacturers, but only if they can adapt to a…

The relatively strong growth will primarily be driven by the increase in diagnosed prevalent cases

Growth will not be aided by the weak anti-hypertensive pipeline, due to lack of innovative products in late-stage development

Dr. Amir Ullah Khan, Visiting Professor, ISB and Director, Research, Aequitas Health Consulting cautions that access to quality…

According to GlobalData, the growth will be driven by factors include an increase in the incidence of myelofibrosis, and a rise in…

Dr Gopakumar G Nair, CEO, Gopakumar Nair Associates, gives an insight on various regulatory hurdles hindering the growth of the…

Bejon Kumar Misra, Founder, Partnership for Safe Medicines (PSM) India Initiative, feels that online pharmacies are here to stay…

Dr J Vijay Venkatraman, MD and CEO, Oviya MedSafe and Karunakaran Shanmugam, QA Associate, Oviya MedSafe,advocate implementing…

Sumit Seth, Partner, Price Waterhouse & Co explains how the introduction of the new accounting standards will impact the…